R van Eekelen
Overview
Explore the profile of R van Eekelen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schuster H, Breedveld A, Matamoros S, van Eekelen R, Painter R, Kok M, et al.
Microbiome
. 2024 May;
12(1):99.
PMID: 38802950
Background: Vaginal microbiota composition is associated with spontaneous preterm birth (sPTB), depending on ethnicity. Host-microbiota interactions are thought to play an important underlying role in this association between ethnicity, vaginal...
2.
Wessel J, Danhof N, van Eekelen R, Diamond M, Legro R, Peeraer K, et al.
Hum Reprod Update
. 2022 May;
28(5):733-746.
PMID: 35587030
Background: Intrauterine insemination with ovarian stimulation (IUI-OS) is a first-line treatment for unexplained infertility. Gonadotrophins, letrozole and clomiphene citrate (CC) are commonly used agents during IUI-OS and have been compared...
3.
van Hoogenhuijze N, van Eekelen R, Mol F, Schipper I, Groenewoud E, Traas M, et al.
Hum Reprod
. 2021 Dec;
37(2):254-263.
PMID: 34864993
Study Question: Is a single endometrial scratch prior to the second fresh IVF/ICSI treatment cost-effective compared to no scratch, when evaluated over a 12-month follow-up period? Summary Answer: The incremental...
4.
van Eekelen R, Wang R, Danhof N, Mol F, Mochtar M, Mol B, et al.
Hum Reprod
. 2021 Feb;
36(5):1288-1295.
PMID: 33615360
Study Question: Which agent for ovarian stimulation (OS) is the most cost-effective option in terms of net benefit for couples with unexplained subfertility undergoing IUI? Summary Answer: In settings where...
5.
van Eekelen R, Rosielle K, van Welie N, Dreyer K, van Wely M, Mol B, et al.
Hum Reprod Open
. 2021 Feb;
2020(4):hoaa047.
PMID: 33598567
Study Question: Can we replicate the finding that the benefit of IUI-ovarian stimulation (IUI-OS) compared to expectant management for couples with unexplained subfertility depends on the prognosis of natural conception?...
6.
7.
van Eekelen R, Eijkemans M, Mochtar M, Mol F, Mol B, Groen H, et al.
Hum Reprod
. 2020 Sep;
PMID: 32876323
Study Question: Over a time period of 3 years, which order of expectant management (EM), IUI with ovarian stimulation (IUI-OS) and IVF is the most cost-effective for couples with unexplained...
8.
Chua S, Danhof N, Mochtar M, van Wely M, McLernon D, Custers I, et al.
Hum Reprod
. 2020 Jul;
35(8):1808-1820.
PMID: 32696041
Study Question: What is the rate of natural conception leading to ongoing pregnancy or livebirth over 6-12 months for infertile women of age ≥35 years? Summary Answer: Natural conception rates...
9.
Danhof N, van Eekelen R, Repping S, Mol B, van der Veen F, van Wely M, et al.
Hum Reprod Open
. 2020 Jan;
2020(1):hoz024.
PMID: 31934648
Study Question: What is, in couples with unexplained subfertility undergoing IUI, the impact of gonadotrophins compared to clomiphene citrate (CC) on endometrial thickness (EMT) in relation to ongoing pregnancy? Summary...
10.
van Eekelen R, van Geloven N, van Wely M, Bhattacharya S, van der Veen F, Eijkemans M, et al.
Hum Reprod
. 2019 Jun;
34(7):1249-1259.
PMID: 31194864
Study Question: Which couples with unexplained subfertility can expect increased chances of ongoing pregnancy with IVF compared to expectant management? Summary Answer: For couples in which the woman is under...